Latest news
Loading news…
Quintiles is a provider of biopharmaceutical development and commercial outsourcing services for drugs on the market.
Quintiles was acquired by IMS Health in 2016 for $9B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
18
Investments
4
2 exits
Monthly Visits
Available in Pro Contacts
40
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 76
- Mobile apps
- 1
- Active products
- 23
- IT spend
- $1B
Investor Activity
- Investments
- 4
- Portfolio orgs
- 3
- Exits
- 2
- Exits via IPO
- 2
Company Info
- Org types
- company, investor
- HQ
- Durham, North Carolina, United States
Signals & Scores
- Trend (7d)
- -0.2
- Trend (30d)
- -0.1
- Trend (90d)
- -0.8
Investments by Quintiles
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Quintiles
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Quintiles
Board of Director
Senior Vice President, Therapeutic & Specialty Business Development
Senior Medical Director
Board of Director
Chief Financial Officer
Chief Medical and Scientific Officer
Senior Scientific Advisor, Strategic Drug Development
40
professional contacts at Quintiles
Contact execs at Quintiles →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Quintiles
Loading news…
FAQs about Quintiles
People who checked this page also checked these
Sectors Quintiles invests & acquires in
Browse the full Acquirezy directory.